Litcius/Paper detail

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine

Clare Morlidge, Sally El‐Kateb, Praveen Jeevaratnam, Barbara Thompson

2021Kidney International51 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)MedicineVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPneumococcal diseaseInfluenza vaccineVirologyMeningococcal diseaseMeningococcal vaccineImmunologyImmune systemDiseaseNeisseria meningitidisInfectious disease (medical specialty)Streptococcus pneumoniaeInternal medicineOutbreakImmunizationMicrobiologyBiologyGeneticsBacteriaAntibioticsSARS-CoV-2 and COVID-19 ResearchInfectious Encephalopathies and EncephalitisPeripheral Neuropathies and Disorders
Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine | Litcius